<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotics for community‐acquired pneumonia in adult outpatients - Pakhale, S - 2014 | Cochrane Library</title> <meta content="Antibiotics for community‐acquired pneumonia in adult outpatients - Pakhale, S - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002109.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotics for community‐acquired pneumonia in adult outpatients - Pakhale, S - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002109.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002109.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotics for community‐acquired pneumonia in adult outpatients" name="citation_title"/> <meta content="Smita Pakhale" name="citation_author"/> <meta content="The Ottawa Hospital, Ottawa Hospital Research Institute and the University of Ottawa" name="citation_author_institution"/> <meta content="spakhale@ohri.ca" name="citation_author_email"/> <meta content="Sunita Mulpuru" name="citation_author"/> <meta content="The Ottawa Hospital, General Campus" name="citation_author_institution"/> <meta content="Theo JM Verheij" name="citation_author"/> <meta content="University Medical Center Utrecht" name="citation_author_institution"/> <meta content="Michael M Kochen" name="citation_author"/> <meta content="University of Göttingen Medical School" name="citation_author_institution"/> <meta content="Gernot GU Rohde" name="citation_author"/> <meta content="Lise M Bjerre" name="citation_author"/> <meta content="University of Ottawa" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD002109.pub4" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/10/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002109.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002109.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002109.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Bacterial Agents [adverse effects, *therapeutic use]; Community‐Acquired Infections [drug therapy]; Outpatients; Pneumonia [*drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002109.pub4&amp;doi=10.1002/14651858.CD002109.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002109\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002109\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","ms","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002109.pub4",title:"Antibiotics for community\\u2010acquired pneumonia in adult outpatients",firstPublishedDate:"Oct 9, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002109.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002109.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002109.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002109.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002109.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002109.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002109.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002109.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002109.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002109.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14032 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002109.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-sec-0089"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-sec-0083"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/appendices#CD002109-sec-0094"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/table_n/CD002109StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/table_n/CD002109StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotics for community‐acquired pneumonia in adult outpatients</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#CD002109-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Smita Pakhale</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#CD002109-cr-0003">Sunita Mulpuru</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#CD002109-cr-0004">Theo JM Verheij</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#CD002109-cr-0005">Michael M Kochen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#CD002109-cr-0006">Gernot GU Rohde</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information#CD002109-cr-0007">Lise M Bjerre</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information/en#CD002109-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 October 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002109.pub4">https://doi.org/10.1002/14651858.CD002109.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002109-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002109-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002109-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002109-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002109-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD002109-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002109-abs-0001" lang="en"> <section id="CD002109-sec-0001"> <h3 class="title" id="CD002109-sec-0001">Background</h3> <p>Lower respiratory tract infection (LRTI) is the third leading cause of death worldwide and the first leading cause of death in low‐income countries. Community‐acquired pneumonia (CAP) is a common condition that causes a significant disease burden for the community, particularly in children younger than five years, the elderly and immunocompromised people. Antibiotics are the standard treatment for CAP. However, increasing antibiotic use is associated with the development of bacterial resistance and side effects for the patient. Several studies have been published regarding optimal antibiotic treatment for CAP but many of these data address treatments in hospitalised patients. This is an update of our 2009 Cochrane Review and addresses antibiotic therapies for CAP in outpatient settings. </p> </section> <section id="CD002109-sec-0002"> <h3 class="title" id="CD002109-sec-0002">Objectives</h3> <p>To compare the efficacy and safety of different antibiotic treatments for CAP in participants older than 12 years treated in outpatient settings with respect to clinical, radiological and bacteriological outcomes. </p> </section> <section id="CD002109-sec-0003"> <h3 class="title" id="CD002109-sec-0003">Search methods</h3> <p>We searched CENTRAL (2014, Issue 1), MEDLINE (January 1966 to March week 3, 2014), EMBASE (January 1974 to March 2014), CINAHL (2009 to March 2014), Web of Science (2009 to March 2014) and LILACS (2009 to March 2014). </p> </section> <section id="CD002109-sec-0004"> <h3 class="title" id="CD002109-sec-0004">Selection criteria</h3> <p>We looked for randomised controlled trials (RCTs), fully published in peer‐reviewed journals, of antibiotics versus placebo as well as antibiotics versus another antibiotic for the treatment of CAP in outpatient settings in participants older than 12 years of age. However, we did not find any studies of antibiotics versus placebo. Therefore, this review includes RCTs of one or more antibiotics, which report the diagnostic criteria and describe the clinical outcomes considered for inclusion in this review. </p> </section> <section id="CD002109-sec-0005"> <h3 class="title" id="CD002109-sec-0005">Data collection and analysis</h3> <p>Two review authors (LMB, TJMV) independently assessed study reports in the first publication. In the 2009 update, LMB performed study selection, which was checked by TJMV and MMK. In this 2014 update, two review authors (SP, SM) independently performed and checked study selection. We contacted trial authors to resolve any ambiguities in the study reports. We compiled and analysed the data. We resolved differences between review authors by discussion and consensus. </p> </section> <section id="CD002109-sec-0006"> <h3 class="title" id="CD002109-sec-0006">Main results</h3> <p>We included 11 RCTs in this review update (3352 participants older than 12 years with a diagnosis of CAP); 10 RCTs assessed nine antibiotic pairs (3321 participants) and one RCT assessed four antibiotics (31 participants) in people with CAP. The study quality was generally good, with some differences in the extent of the reporting. A variety of clinical, bacteriological and adverse events were reported. Overall, there was no significant difference in the efficacy of the various antibiotics. Studies evaluating clarithromycin and amoxicillin provided only descriptive data regarding the primary outcome. Though the majority of adverse events were similar between all antibiotics, nemonoxacin demonstrated higher gastrointestinal and nervous system adverse events when compared to levofloxacin, while cethromycin demonstrated significantly more nervous system side effects, especially dysgeusia, when compared to clarithromycin. Similarly, high‐dose amoxicillin (1 g three times a day) was associated with higher incidence of gastritis and diarrhoea compared to clarithromycin, azithromycin and levofloxacin. </p> </section> <section id="CD002109-sec-0007"> <h3 class="title" id="CD002109-sec-0007">Authors' conclusions</h3> <p>Available evidence from recent RCTs is insufficient to make new evidence‐based recommendations for the choice of antibiotic to be used for the treatment of CAP in outpatient settings. Pooling of study data was limited by the very low number of studies assessing the same antibiotic pairs. Individual study results do not reveal significant differences in efficacy between various antibiotics and antibiotic groups. However, two studies did find significantly more adverse events with use of cethromycin as compared to clarithromycin and nemonoxacin when compared to levofloxacin. Multi‐drug comparisons using similar administration schedules are needed to provide the evidence necessary for practice recommendations. Further studies focusing on diagnosis, management, cost‐effectiveness and misuse of antibiotics in CAP and LRTI are warranted in high‐, middle‐ and low‐income countries. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002109-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002109-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002109-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002109-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002109-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD002109-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD002109-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD002109-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD002109-abs-0006">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002109-abs-0005" lang="en"> <h3>Antibiotics for community‐acquired pneumonia in adolescent and adult outpatients</h3> <p><b>Review question</b> </p> <p>This review studied the effects of antibiotics on adolescents and adults with pneumonia acquired and treated in the community (as opposed to acquiring pneumonia in hospital and/or being treated for pneumonia in hospital). The evidence is current to March 2014. </p> <p><b>Background</b> </p> <p>Lower respiratory tract infection is the third leading cause of death worldwide and the first leading cause of death in low‐income countries. Pneumonia, or infection of the lungs, is a common condition representing a significant disease burden for the community. Pneumonia is especially life‐threatening in children younger than five years, in older people and in people with other illnesses that may affect their immune system (such as diabetes or HIV/AIDS, or solid organ transplant recipients). Antibiotics are the most common treatment for pneumonia and these can vary in their effectiveness and adverse effects. </p> <p><b>Study characteristics</b> </p> <p>We identified 11 trials (with 3352 participants older than 12 years with a diagnosis of community‐acquired pneumonia), fully published in peer‐reviewed journals, focused on treatment of pneumonia in adolescents and adults treated in the community in outpatient settings. This included five new trials included since our last review published in 2009. None of the trials included antibiotics versus placebo; all trials included one or more antibiotics. All participants were diagnosed with pneumonia based upon clinical diagnosis by the physician and chest X‐ray. </p> <p><b>Study funding sources</b> </p> <p>All included trials were well conducted; nine of the 11 trials were sponsored by bio‐pharmaceutical companies manufacturing the antibiotics used in the study, or their authors were closely linked with the company. </p> <p><b>Key results</b> </p> <p>Nine of the included trials compared different antibiotics and, hence, we could not combine the results of the individual trials to present our overall conclusion. There were some notable adverse events in seven studies: 1) erythromycin demonstrated significant gastrointestinal side effects compared to clarithromycin in two studies; 2) nemonoxacin demonstrated higher gastrointestinal (nausea, diarrhoea) and nervous system (dizziness, headache) adverse events compared to levofloxacin; 3) cethromycin demonstrated more side effects, especially a distortion of the sense of taste, than clarithromycin; 4) gastritis and diarrhoea were more common in the high‐dose amoxicillin group (1 g three times a day) compared to the other three antibiotic groups (clarithromycin, azithromycin and levofloxacin). </p> <p><b>Conclusion</b> </p> <p>Unfortunately, there were not enough trials to compare the effects of different antibiotics for pneumonia acquired and treated in the community. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002109-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002109-sec-0089"></div> <h3 class="title" id="CD002109-sec-0090">Implications for practice</h3> <section id="CD002109-sec-0090"> <p>Currently available evidence from randomised controlled trials (RCTs) is insufficient to make evidence‐based recommendations for the choice of antibiotic to be used in the treatment of community‐acquired pneumonia (CAP) in ambulatory patients. At most, it can be stated that individual study results do not reveal significant differences in efficacy between various antibiotics and antibiotic groups. </p> </section> <h3 class="title" id="CD002109-sec-0091">Implications for research</h3> <section id="CD002109-sec-0091"> <p>Multi‐drug, multi‐drug‐group, double‐blind comparisons conducted in various geographical settings are needed to provide the evidence necessary for practice recommendations if these are to be applicable in the ambulatory setting. Study conditions should ensure that diagnosis and management of patients with CAP is as similar as possible to real practice, while still ensuring that the study question is addressed in a valid way. In studies recruiting a mix of in‐ and outpatients, it is imperative that data be reported separately for these two subgroups. Finally, good quality studies are needed in high as well as low‐ and middle‐income countries to address CAP and lower respiratory tract infection diagnosis, management, cost‐effectiveness and misuse of antibiotics. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002109-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD002109-sec-0029"></div> <section id="CD002109-sec-0030"> <h3 class="title" id="CD002109-sec-0030">Description of the condition</h3> <p>Community‐acquired pneumonia (CAP), which excludes cases acquired in hospital, nursing homes and long‐term care facilities, is a common condition that carries a high burden of mortality and morbidity. This burden is carried particularly in children younger than five years, the elderly and immunocompromised people. Prospective studies conducted in the United Kingdom, Finland and the United States have estimated the annual incidence of CAP in community‐dwelling adults at 5 to 11 cases per 1000 adult population; the incidence is known to vary markedly with age, being higher in the very young and the elderly (<a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>; <a href="./references#CD002109-bbs2-0130" title="FoyHM , CooneyMK , AllanI , KennyGE . Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA1979;241:253‐8. ">Foy 1979</a>; <a href="./references#CD002109-bbs2-0137" title="JokinenC , HeiskanenL , JuvonenH , KallinenS , KarkolaK , KorppiM , et al. Incidence of community‐acquired pneumonia in the population of four municipalities in eastern Finland. American Journal of Epidemiology1993;137:977‐88. ">Jokinen 1993</a>; <a href="./references#CD002109-bbs2-0150" title="TorresA , Serra‐BatllesJ , FerrerA , JiménezP , CelisR , CoboE , et al. Severe community‐acquired pneumonia. Epidemiology and prognostic factors. American Review of Respiratory Disease1991;144:312‐8. ">Torres 1991</a>; <a href="./references#CD002109-bbs2-0153" title="WoodheadMA , MacfarlaneJT , McCrackenJS , RoseDH , FinchRG . Prospective study of the aetiology and outcome of pneumonia in the community. Lancet1987;i:671‐4. ">Woodhead 1987</a>). </p> <p>CAP is the most important cause of death from infectious causes in high‐income countries and the seventh most important cause of death overall (<a href="./references#CD002109-bbs2-0136" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">IDSA/ATS 2007</a>; <a href="./references#CD002109-bbs2-0143" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">Mandell 2007</a>). CAP can be caused by a broad range of pathogens, including bacteria, atypical bacteria <i>Chlamydophila pneumoniae</i> (<i>C. pneumoniae</i> ),<i>Mycoplasma pneumoniae</i> (<i>M. pneumoniae</i> ), <i>Legionella pneumophila</i> (<i>L. pneumophila</i>) and viruses (<a href="./references#CD002109-bbs2-0136" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">IDSA/ATS 2007</a>; <a href="./references#CD002109-bbs2-0143" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">Mandell 2007</a>; <a href="./references#CD002109-bbs2-0151" title="WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. ">Welte 2012</a>). In fact, more than 100 different micro‐organisms have been associated with CAP (<a href="./references#CD002109-bbs2-0140" title="LoebM . Community‐acquired pneumonia. Clinical Evidence. Vol. 8, London: BMJ Publishing Group, 2002. ">Loeb 2002</a>). Furthermore, a patient with CAP can be infected with more than one microbe, as in the case of a bacterial superinfection of an underlying influenza infection. The most common pathogens in normal hosts include <i>Streptococcus pneumoniae</i> (<i>S. pneumoniae</i> ) (usually by far the most common),<i>C. pneumoniae</i> ,<i>Haemophilus influenzae</i> (<i>H. influenzae</i> ),<i>M. pneumoniae</i> and influenza viruses (<a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>; <a href="./references#CD002109-bbs2-0136" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">IDSA/ATS 2007</a>; <a href="./references#CD002109-bbs2-0140" title="LoebM . Community‐acquired pneumonia. Clinical Evidence. Vol. 8, London: BMJ Publishing Group, 2002. ">Loeb 2002</a>; <a href="./references#CD002109-bbs2-0143" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">Mandell 2007</a>; <a href="./references#CD002109-bbs2-0151" title="WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. ">Welte 2012</a>). </p> <p>Significant costs are associated with the diagnosis and management of CAP. In the UK, 22% to 42% of adults with CAP are admitted to hospital (<a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>) and of those 1.2% to 10% need to be admitted to an intensive care unit (<a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>). In a recent European review, pneumonia accounted for 10.1 billion Euros annually (<a href="./references#CD002109-bbs2-0151" title="WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. ">Welte 2012</a>). </p> </section> <section id="CD002109-sec-0031"> <h3 class="title" id="CD002109-sec-0031">Description of the intervention</h3> <p>Antibiotics are the mainstay of treatment for CAP and the causative organisms usually respond well. Consequently, CAP treatment is associated with the development of bacterial resistance. In treating patients with CAP, the choice of antibiotic is a difficult one. Factors that must be considered are the possible aetiologic pathogen, the efficacy of the substance, potential side effects, the treatment schedule, patient adherence to treatment, the particular regional resistance profile of the causative organism, common pathogens in particular age groups (children versus elderly), co‐morbidities that might influence the range of potential pathogens (such as in cystic fibrosis or solid organ transplant recipients), the dosage of antibiotics (as in the case of renal insufficiency) and the clinical severity of CAP. </p> </section> <section id="CD002109-sec-0032"> <h3 class="title" id="CD002109-sec-0032">How the intervention might work</h3> <p>Bacterial pathogens remain the most common causative agents of CAP. Use of appropriate antibiotics is essential, otherwise the chosen antibiotic may not be effective and could pose a danger to the patient due to side effects. If a specific pathogen has been identified, antibiotic therapy should be directed at this pathogen, so that it is more effective and less harmful. </p> </section> <section id="CD002109-sec-0033"> <h3 class="title" id="CD002109-sec-0033">Why it is important to do this review</h3> <p>Many clinical trials have been performed to evaluate and compare the efficacy of antibiotics for CAP. However, the vast majority of them were conducted in hospitalised patients. These patients usually suffer from more severe manifestations of the disease and often have other co‐morbid conditions that affect their response to treatment and their time to recovery. Consequently, it is unclear if results of therapy in hospitalised patients can be extrapolated to outpatients. Numerous guidelines exist to aid clinicians with the treatment of CAP: in recent years, guidelines have been published by the American Thoracic Society (<a href="./references#CD002109-bbs2-0125" title="American Thoracic Society. Guidelines for the management of adults with community‐acquired pneumonia. American Journal of Critical Care2001;163:1730‐54. ">ATS 2001</a>), the Infectious Diseases Society of America (<a href="./references#CD002109-bbs2-0134" title="Infectious Diseases Society of America. Practice guidelines for the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2000;31:347‐82. ">IDSA 2000</a>, updated December 2003 and later in 2007; <a href="./references#CD002109-bbs2-0135" title="Infectious Diseases Society of America. Update of practice guidelines for the management of community‐acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases2003;37:1405‐33. ">IDSA 2003</a>; <a href="./references#CD002109-bbs2-0136" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">IDSA/ATS 2007</a>; <a href="./references#CD002109-bbs2-0143" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">Mandell 2007</a>), the British Thoracic Society (<a href="./references#CD002109-bbs2-0126" title="MacfarlaneJT , BoldyD . 2004 update of BTS pneumonia guidelines: what's new?. Thorax2004;59(5):364‐6. [Macfarlane 2004; www.brit‐thoracic.org.uk/guidelines] ">BTS 2004</a>; update: <a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>), the Canadian Community‐Acquired Pneumonia Working Group (<a href="./references#CD002109-bbs2-0129" title="Canadian Community‐Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community‐acquired pneumonia: an evidence‐based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clinical Infectious Diseases2000;31:383‐421. ">CCAPWG 2000</a>), the European Respiratory Society (<a href="./references#CD002109-bbs2-0154" title="WoodheadM ,  BlasiF ,  EwigS ,  GarauJ ,  HuchonG ,  IevenM ,  etal . Guidelines for the management of adult lower respiratory tract infections‐‐full version. Clinical Microbiology and Infection2011;17(Suppl 6):E1‐59. ">Woodhead 2011</a>), a German Guidelines Group (<a href="./references#CD002109-bbs2-0133" title="HöffkenG , LorenzJ , KernW , WelteT , BauerT , DalhoffK , et al. Guidelines of the Paul‐Ehrlich‐Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community Acquired Pneumonia: Summary of the Update 2009. Pneumologie2010;64:149‐54. [German guidelines 2009] ">Höffken 2010</a>), a Dutch CAP Guidelines group (<a href="./references#CD002109-bbs2-0152" title="WiersingaWJ , BontenMJ , BoersmaWG , JonkersRE , AlevaRM , KullbergBJ , et al. Dutch guidelines on the management of community‐acquired pneumonia in adults. SWAB/NVALT Guidelines Community‐acquired Pneumonia2011. ">Wiersinga 2011</a>), the Gulf Cooperation Council (<a href="./references#CD002109-bbs2-0144" title="MemishZA , ArabiYM , AhmedQA , ShiblAM , NiedermanMS , GCC CAP Working Group. Executive summary of the Gulf Cooperation Council practice guidelines for the management of community‐acquired pneumonia. Journal of Chemotherapy2007;19(Suppl 1):7‐11. [Memish 2007] ">Memish 2007</a>), the Japanese Respiratory Society (<a href="./references#CD002109-bbs2-0138" title="Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections. Guidelines for the management of community acquired pneumonia in adults, revised edition. Respirology2006;11(Suppl 3):79‐133. ">JRS 2006</a>), the Latin American Thoracic Association (<a href="./references#CD002109-bbs2-0122" title="Grupo de trabajo de la Asociación Latinoamericana del Tórax(ALAT) . Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia [Recomendaciones ALAT sobre la neumonía adquirida en la comunidad]. Archivos de Bronconeumología2001;37:340‐8. ">ALAT 2001</a>, update: <a href="./references#CD002109-bbs2-0123" title="Grupo de trabajo de la Asociación Latinoamericana del Tórax(ALAT) . Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia. Archivos de Bronconeumología2004;40(8):364‐74. ">ALAT 2004</a>), the South African Thoracic Society (<a href="./references#CD002109-bbs2-0147" title="Working Group of the South African Thoracic Society. Management of community‐acquired pneumonia in adults. South African Medical Journal2007;97(12 Pt 2):1296‐306. ">SATS 2007</a>) and the Swedish Society of Infectious Diseases (<a href="./references#CD002109-bbs2-0131" title="HedlundJ , StrålinK , OrtqvistA , HolmbergH , Community‐Acquired Pneumonia Working Group of the Swedish Society of Infectious Diseases. Swedish guidelines for the management of community‐acquired pneumonia in immunocompetent adults. Scandinavian Journal of Infectious Diseases2005;37(11‐2):791‐805. ">Hedlund 2005</a>; update: <a href="./references#CD002109-bbs2-0149" title="StrålinK , GoscinskiG , HedlundJ , LidmanC , SpindlerC , OrtqvistA , et al. Management of adult patients with community‐acquired pneumonia. Evidence‐based guidelines from the Swedish Infectious Diseases Association [Handläggning av samhälls‐förvärvad pneumoni hos vuxna. Evidensbaserade riktlinjer från Svenska infektionsläkarföreningen. (Abridged version of the 2007 update; http://www.infektion.net/klinik/lunga/pneumoni/Vardprogram_Pneumoni_slutvers_2007.pdf (in Swedish) (accessed 23 March 2009)]. Lakartidningen2008;105(38):2582‐7. ">Strålin 2007</a>; <a href="./references#CD002109-bbs2-0148" title="SpindlerC , StrålinK , ErikssonL , Hjerdt‐GoscinskiG , HolmbergH , LidmanC , et al. Swedish guidelines on the management of community‐acquired pneumonia in immunocompetent adults‐‐Swedish Society of Infectious Diseases 2012. Scandinavian Journal of Infectious Diseases2012;44(12):885‐902. ">Spindler 2012</a>). All these guidelines include recommendations for the choice of antibiotic treatment for CAP in outpatient settings. However, the evidence on which these recommendations are based is derived mainly from studies carried out almost exclusively in hospitalised patients. Although many studies have been published concerning CAP and its treatment, there is no concise summary of the available evidence concerning its treatment in unselected ambulatory outpatients. </p> <p>This review is an update of our review (<a href="./references#CD002109-bbs2-0155" title="BjerreLM , VerheijTJ , KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD002109.pub2] ">Bjerre 2004</a>; <a href="./references#CD002109-bbs2-0156" title="BjerreLM ,  VerheijTJ ,  KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002109.pub3] ">Bjerre 2009</a>), and addresses the comparative efficacy of new antibiotic treatments for CAP in outpatients above 12 years of age. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002109-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002109-sec-0034"></div> <p>To compare the efficacy and safety of different antibiotic treatments for CAP in participants older than 12 years treated in outpatient settings with respect to clinical, radiological and bacteriological outcomes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002109-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002109-sec-0035"></div> <section id="CD002109-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002109-sec-0037"> <h4 class="title">Types of studies</h4> <p>We looked for studies comparing antibiotics versus placebo, as well as antibiotics versus another antibiotic. However, we did not find studies comparing antibiotics versus placebo. Therefore, we included RCTs of one or more antibiotics in adolescent and adult outpatients with CAP, which reported on clinical outcome parameters, clinical cure rates or bacteriologic response, or both, and adverse events. </p> </section> <section id="CD002109-sec-0038"> <h4 class="title">Types of participants</h4> <p>Participants older than 12 years of age in outpatient settings with the following.</p> <p> <ol id="CD002109-list-0001"> <li> <p>Symptoms and signs consistent with an acute lower respiratory tract infection associated with new radiographic shadowing for which there is no other explanation (for example, not pulmonary oedema or infarction). </p> </li> <li> <p>The illness is the primary clinical problem and is managed as pneumonia.</p> </li> </ol> </p> <p>(Modified from the criteria for CAP as defined by the British Thoracic Society (<a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>)). </p> </section> <section id="CD002109-sec-0039"> <h4 class="title">Types of interventions</h4> <p>We considered all double‐blind RCTs comparing one antibiotic and a placebo or at least two antibiotics used to treat CAP. We did not include trials comparing two doses, two treatment durations or two different application methods (example: intravenous versus oral) of the same drug. However, we included trials comparing two different pharmacological formulations of the same substance (for example, microspheres versus pure substance), as they are likely to differ in their pharmacodynamic and pharmacokinetic properties and thus may differ in their efficacy. </p> <p>Comparisons involving intravenous drugs are usually carried out in a hospital setting. However, as this might occasionally be performed in an ambulatory setting, we did not exclude studies dealing with intravenous drug applications a priori. </p> <p>We included trials allowing concurrent use of other medications, such as antitussives, antipyretics, bronchodilators or mucolytics, if they allowed equal access to such medications for participants in both arms of the trial. </p> </section> <section id="CD002109-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD002109-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD002109-list-0002"> <li> <p>Test‐of‐clinical‐cure: clinical response: improvement of signs and symptoms, usually at a pre‐defined test‐of‐cure (TOC) visit. Where possible, we used duration of clinical signs and symptoms as outcome measures. We used a clinical definition of cure as the primary outcome since radiographic resolution lags behind clinical improvement (<a href="./references#CD002109-bbs2-0141" title="MacfarlaneJT , MillerAC , Roderick SmithWH , MorrisAH , RoseDH . Comparative radiographic features of community‐acquired legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis. Thorax1984;39:28‐33. ">Macfarlane 1984</a>). </p> </li> </ol> </p> </section> <section id="CD002109-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD002109-list-0003"> <li> <p>Radiologic response: resolution or improvement of a new finding on chest X‐ray after antibiotic therapy. </p> </li> <li> <p>Bacteriologic response: negative sputum culture in patients previously found to have had pathogens in their sputum. </p> </li> <li> <p>Adverse events: adverse events related to the intervention were reported.</p> </li> <li> <p>Hospitalisation.</p> </li> <li> <p>Mortality.</p> </li> </ol> </p> </section> </section> </section> <section id="CD002109-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD002109-sec-0044"> <h4 class="title">Electronic searches</h4> <p>For this 2014 update, to improve our comprehensiveness and coverage of the literature, we edited our search strategy and extended our searches of the electronic databases to include CINAHL, Web of Science and LILACS. Details of the previous search are in <a href="./appendices#CD002109-sec-0095">Appendix 1</a>. </p> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 1) (accessed 28 March 2014), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (January 2009 to March week 3, 2014), EMBASE (February 2009 to March 2014), CINAHL (2009 to March 2014), Web of Science (2009 to March 2014) and LILACS (2009 to March 2014). </p> <p>We searched MEDLINE and CENTRAL using the search strategy shown below. We combined the MEDLINE search strategy with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐and precision‐maximising version (2008 revision) (<a href="./references#CD002109-bbs2-0139" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. ">Lefebvre 2011</a>). We adapted the search strategy for EMBASE (<a href="./appendices#CD002109-sec-0096">Appendix 2</a>), CINAHL (<a href="./appendices#CD002109-sec-0097">Appendix 3</a>), Web of Science (<a href="./appendices#CD002109-sec-0098">Appendix 4</a>) and LILACS (<a href="./appendices#CD002109-sec-0099">Appendix 5</a>). </p> <p><b>MEDLINE (Ovid)</b> </p> <p>1 exp Pneumonia/<br/> 2 pneumonia.tw.<br/> 3 1 or 2<br/> 4 Community‐Acquired Infections/<br/> 5 community‐acquired.tw.<br/> 6 Outpatients/ (7479)<br/> 7 (outpatient* or out‐patient*).tw.<br/> 8 exp Ambulatory Care/<br/> 9 (ambulat* adj2 (care or patient*)).tw.<br/> 10 or/4‐9<br/> 11 3 and 10<br/> 12 (community acquired pneumon* or cap).tw.<br/> 13 11 or 12<br/> 14 exp Anti‐Bacterial Agents/<br/> 15 antibiotic*.tw.<br/> 16 exp Macrolides/<br/> 17 exp beta‐Lactams/<br/> 18 exp Quinolones/<br/> 19 exp Tetracyclines/<br/> 20 (beta‐lactam* or macrolide* or makrolide* or quinolone* or tetracycline* or aciclovir or amikacin or amoxicillin or amoxycillin or ampicillin or azithromycin or cefepim or cefotaxim* or ceftarolin or ceftazidim* or ceftibuten or ceftriaxon* or cefuroxim* or cethromycin or ciprofloxacin or clarithromycin or clavulanic acid or clindamycin or co‐amoxiclav or co‐trimoxacol or doxycyclin* or ertapenem or erythromycin or fluoroquinolon* or fluorchinolon* or gemifloxacin or gentamicin or imipenem or levofloxacin or linezolide or meropenem or moxifloxacin or penicillin* or piperacillin or roxithromycin or sultamicillin or tazobactam or telithromycin or tetracyclin* or ticarcillin or tobramycin).tw,nm.<br/> 21 or/14‐20<br/> 22 13 and 21 </p> </section> <section id="CD002109-sec-0045"> <h4 class="title">Searching other resources</h4> <p>We also identified studies by checking the bibliographies of studies and review articles retrieved and, if necessary, by contacting the first or corresponding authors of relevant studies. In our first review of this topic, published in 2004 (<a href="./references#CD002109-bbs2-0155" title="BjerreLM , VerheijTJ , KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD002109.pub2] ">Bjerre 2004</a>), we had contacted the following antibiotics manufacturers to identify any additional published or unpublished studies: Abbott, AstraZeneca, Aventis, Boehringer‐Ingelheim, Bristol‐Myers‐Squibb, GlaxoSmithKline, Hoffmann‐LaRoche, Lilly, Merck, Merck Sharp &amp; Dohme, Novartis, Pfizer, Pharmacia, Sanofi and Yamanouchi. This search yielded no new studies. </p> <p>We decided not to contact pharmaceutical companies for future review updates. We made this decision for two reasons: first, because of the very low yield of this search strategy, compared to the significant amount of time it requires; and second, because this search strategy provides an unfair advantage to unpublished studies carried out by industry, as opposed to government or academia, where an equivalent search strategy is not readily available. For the same reason, we decided only to include studies that have been fully published in peer‐reviewed journals. We applied no language restrictions to the search and selection process. </p> </section> </section> <section id="CD002109-sec-0046"> <h3 class="title" id="CD002109-sec-0046">Data collection and analysis</h3> <section id="CD002109-sec-0047"> <h4 class="title">Selection of studies</h4> <p>Two or one review authors (SP and SM for this 2014 update; and LMB and TJMV for the 2004 update; and LMB for the 2009 update) used the titles and abstracts of the identified citations to exclude trials that clearly did not meet our inclusion criteria in the previous two publications of this review (<a href="./references#CD002109-bbs2-0155" title="BjerreLM , VerheijTJ , KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD002109.pub2] ">Bjerre 2004</a>; <a href="./references#CD002109-bbs2-0156" title="BjerreLM ,  VerheijTJ ,  KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002109.pub3] ">Bjerre 2009</a>). If the review authors felt that a study might possibly fulfil the inclusion criteria, we obtained the full paper for further study. </p> <p>Two review authors (LMB, TJMV in the first review, LMB in the second review and SP, SM in this updated review) independently reviewed articles having passed this initial screen to determine whether they met the inclusion criteria of the review. </p> <p>Studies could be excluded for any one of the following reasons: if they were not randomised; if they were conducted exclusively in hospitalised patients; if they only compared two doses or two application forms of the same substance, if the indication for treatment consisted of a mix of diagnoses (most commonly: acute bronchitis, exacerbation of chronic bronchitis and pneumonia) and if the results were not reported separately for each diagnostic group. </p> <p>Another reason for exclusion was that some studies included a mix of in‐ and outpatients without reporting the data separately for these two subgroups. Whenever this was the case, we contacted the trial authors to obtain separate data for outpatients only. </p> <p>We also excluded studies including only bacteriologically evaluable patients, because these studies typically included only patients with positive cultures of pathogens susceptible to study antibiotics or excluded patients with serologic confirmation of infection with atypical agents (such as <i>M. pneumoniae</i> or <i>C. pneumoniae</i>). A priori exclusion of patients with resistant strains, as well as of patients with non‐bacterial or atypical causes of CAP, would falsely increase the treatment success rate to levels that would be unrealistic in real practice. We chose to exclude these 'narrow‐focus' studies because we are interested in the efficacy of treatment in patients as they present to their general practitioner (GP), that is, unselected and unfiltered. We consider this essential to the generalisability of our results. </p> <p>We also excluded studies if the diagnosis of pneumonia was not confirmed by chest X‐ray. This exclusion criterion was necessary to ensure that only participants with a very high likelihood of having pneumonia be included in the review, since this was the patient population in which the efficacy of various treatment alternatives was to be assessed. </p> <p>Furthermore, we excluded studies if the total number of patients was fewer than 30, because below this limit the estimate of a binomial parameter (in this case, the proportion of patients cured or improved) becomes too unstable (<a href="./references#CD002109-bbs2-0124" title="ArmitageP , BerryG . Statistical Methods in Medical Research. 3rd Edition. Oxford: Blackwell Scientific Publications, 1994. ">Armitage 1994</a>). </p> <p>Similar to the previous versions of this review (<a href="./references#CD002109-bbs2-0155" title="BjerreLM , VerheijTJ , KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD002109.pub2] ">Bjerre 2004</a>; <a href="./references#CD002109-bbs2-0156" title="BjerreLM ,  VerheijTJ ,  KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002109.pub3] ">Bjerre 2009</a>), we excluded studies of antibiotics that have been withdrawn from the market or are no longer licensed for the treatment of outpatients with CAP, due to severe adverse effects. For example, we excluded studies assessing the following fluoroquinolones: gatifloxacin, grepafloxacin, sparfloxacin, temafloxacin and trovafloxacin (Black Box Warning: not recommended for CAP because of serious side effects). Consequently, we excluded a study that had been included in the first publication of this review from the present review and the previous update (<a href="./references#CD002109-bbs2-0093" title="RamirezJ , UnowskyJ , TalbotGH , ZhangH , TownsendL . Sparfloxacin vs clarithromycin in the treatment of community acquired pneumonia. Clinical Therapeutics1999;21(1):103‐17. ">Ramirez 1999</a>). </p> </section> <section id="CD002109-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted the following data from each study, whenever possible: </p> <p> <ul id="CD002109-list-0004"> <li> <p>description of participants, in particular: age range and gender of participants, smoking status, co‐morbidities; </p> </li> <li> <p>description of potential pathogens identified and their antimicrobial resistance profiles;</p> </li> <li> <p>description of intervention;</p> </li> <li> <p>description of control therapy;</p> </li> <li> <p>total number of participants in each arm of the trial;</p> </li> <li> <p>study setting;</p> </li> <li> <p>mean duration of symptoms in each arm of the trial;</p> </li> <li> <p>clinical, radiographic and bacteriologic cure rates in each arm of the trial;</p> </li> <li> <p>number of patients lost to follow‐up;</p> </li> <li> <p>types of adverse effects experienced and number of patients experiencing adverse effects;</p> </li> <li> <p>number of drop‐outs due to adverse effects;</p> </li> <li> <p>proportion of patients admitted to hospital in each arm of the trial;</p> </li> <li> <p>mortality rates in each arm of the trial;</p> </li> <li> <p>study sponsor/s and role of sponsor/s in study conception, design, implementation, analysis, manuscript writing and publication. </p> </li> </ul> </p> <p>There were no irreconcilable disagreements. Review authors were not blinded to the identity and affiliation of the study authors. </p> </section> <section id="CD002109-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane 'Risk of bias' tool to systematically assess the risk of bias in included studies (<a href="./references#CD002109-bbs2-0132" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). (See <a href="./references#CD002109-sec-0109" title="">Characteristics of included studies</a> table). </p> </section> <section id="CD002109-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We used the Mantel‐Haenszel approach to estimate the common odds ratios (ORs) with approximate 95% confidence intervals (CIs). This was done using <a href="./references#CD002109-bbs2-0145" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>. </p> </section> <section id="CD002109-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual patient. All included studies were RCTs without any design particularities, such as cross‐over design or multiple interventions, which would warrant special attention to the units of analysis. </p> </section> <section id="CD002109-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We were to deal with missing data arising, for example, from failure to report on outcomes such as radiological cure rates in some studies, by excluding the specific outcome from the 'Data and analysis' section for the study in question. As for data missing from individual studies (more specifically, patients lost to follow‐up), whenever possible, we used data from the clinical per protocol population, because this excluded patients who had not been sufficiently exposed to the study drug to be able potentially to benefit from the drug. </p> </section> <section id="CD002109-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>We carried out the assessment of heterogeneity by means of the Chi<sup>2</sup> test for heterogeneity, available in <a href="./references#CD002109-bbs2-0145" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>. </p> </section> <section id="CD002109-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>If applicable, we assessed reporting/publication bias using funnel plots.</p> </section> <section id="CD002109-sec-0055"> <h4 class="title">Data synthesis</h4> <p>Whenever possible, we synthesised data using a fixed‐effect meta‐analysis model (Mantel‐Haenszel odds ratio, available in <a href="./references#CD002109-bbs2-0145" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD002109-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>As all included studies compared different antibiotic pairs, a subgroup analysis was not possible. </p> </section> <section id="CD002109-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>We did not include studies with fewer than 30 participants in the new review, so no sensitivity analysis was done. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002109-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002109-sec-0058"></div> <section id="CD002109-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD002109-sec-0060"> <h4 class="title">Results of the search</h4> <p>This search yielded a total of 1828 references in our first review (1966 to 2003) (<a href="./references#CD002109-bbs2-0155" title="BjerreLM , VerheijTJ , KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD002109.pub2] ">Bjerre 2004</a>), the second updated search (2003 to 2009) yielded an additional 1298 records and this current updated search (2009 to 2014) yielded 730 records, for a grand total of 3856 records. After independently reading all the selected full articles, we selected 11 studies for this review. Some records were double entries, due to the overlapping content of databases. </p> </section> <section id="CD002109-sec-0061"> <h4 class="title">Included studies</h4> <p>We included 11 RCTs involving a total of 3352 patients aged 12 years and older diagnosed with CAP (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>; <a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a>; <a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>; <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a>; <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>; <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>; <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>; <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a>; <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>). None of the studies included antibiotics versus placebo; all studies included one or more antibiotics. The van Rensburg 2010 article is presented here as <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a> for simplicity as in this article two doses of nemonoxacin were tested against levofloxacin (in 1:1:1 ratio randomisation). The trials included varying numbers of patients, the largest having 1025 participants (<a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>), which is comprised of two studies, the smallest 31 (<a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>). The mean size of studies included in the analysis was 310 participants and the median size was 131 (<a href="#CD002109-fig-0001">Figure 1</a>). <a href="#CD002109-fig-0002">Figure 2</a> is reproduced from the previous review depicting antibiotic pairs included in that review (<a href="./references#CD002109-bbs2-0156" title="BjerreLM ,  VerheijTJ ,  KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002109.pub3] ">Bjerre 2009</a>). </p> <div class="figure" id="CD002109-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Figure1: Antibiotic comparisons in new studies included in this review. The red arrow indicates antibiotic comparisons studied in Udupa 2011." data-id="CD002109-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Figure1: Antibiotic comparisons in new studies included in this review. The red arrow indicates antibiotic comparisons studied in <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>. </p> </div> </div> </div> <div class="figure" id="CD002109-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Figure 2. Overview of included studies and antibiotic pairs studied in 2009 review. *Indicates studies new to this review; shaded ovals indicate quinolones (gyrase inhibitors), white ovals indicate macrolides" data-id="CD002109-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Figure 2. Overview of included studies and antibiotic pairs studied in 2009 review. *Indicates studies new to this review; shaded ovals indicate quinolones (gyrase inhibitors), white ovals indicate macrolides </p> </div> </div> </div> <p>All trials enrolled outpatients with CAP and the diagnosis was based on clinical signs and symptoms as well as radiographic findings in all participants. The signs and symptoms included fever, chills, recent onset of productive cough, pleuritic chest pain, shortness of breath, tachypnoea, dullness to percussion, egophony, rales, localised reduced breath sounds and bronchial breath sounds. In all included trials, participants were treated exclusively as outpatients. </p> <section id="CD002109-sec-0062"> <h5 class="title">Participant inclusion and exclusion criteria</h5> <p>Eight trials included adult participants only, aged 18 years and older. Three trials included adolescents: <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a> included adolescents 12 years of age and older. <a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a> and <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a> included adolescents 16 years of age and older. Three trials included participants aged 75 years and older (24% to 30% greater than 65 years age) (<a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>), and two trials excluded older participants (<a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> excluded participants aged 55 years and older and in <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a> participants up to 80 years were included). Inpatients and outpatients were studied in <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a>, however, results were presented separately for both groups. Overall, the trials excluded patients with conditions that could have affected the treatment or interfered with follow‐up. Exclusion criteria were reported in sufficient detail in all study reports. The most common criteria reported were: pregnancy and lactation, women not using adequate contraception (usually oral contraceptives or a barrier method), history of allergic reaction to the study drugs, recent treatment with or concomitant use of an antimicrobial agent, concurrent medication with ergotamine, cyclosporin, antacids (except H2‐antagonists) or digitalis, conditions affecting gastrointestinal (GI) absorption, severe renal or hepatic impairment, terminal illness or conditions precluding study completion, infectious mononucleosis, HIV/AIDS and prior participation in the study. </p> </section> <section id="CD002109-sec-0063"> <h5 class="title">Antibiotics</h5> <p>The trials varied with respect to the antibiotics studied (<a href="#CD002109-fig-0001">Figure 1</a>; <a href="#CD002109-fig-0002">Figure 2</a>). Four trials studied the same antibiotic pair: <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> and <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a> studied clarithromycin versus amoxicillin and <a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a> and <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a> studied erythromycin versus clarithromycin. However, <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> also studied two additional antibiotics including azithromycin and levofloxacin. All other trials studied different antibiotic pairs, namely clarithromycin versus azithromycin microspheres (<a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a>), clarithromycin versus telithromycin (<a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>), azithromycin microspheres versus levofloxacin (<a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>), telithromycin versus levofloxacin (<a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a>), cethromycin versus clarithromycin (<a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>), solithromycin versus levofloxacin (<a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>), and nemonoxacin versus levofloxacin (<a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>). </p> </section> </section> <section id="CD002109-sec-0064"> <h4 class="title">Excluded studies</h4> <p>We excluded 109 studies. A large number of studies were excluded because they were conducted exclusively in hospitalised participants. Furthermore, a number of studies reported including a mix of in‐ and outpatients without reporting data separately for these two subgroups. For these studies, we contacted the trial authors to try to obtain separate data on outpatients. Out of seven trial authors, only two responded and both were unable to provide us with the necessary data. </p> </section> </section> <section id="CD002109-sec-0065"> <h3 class="title">Risk of bias in included studies</h3> <p>The extent of reporting was variable between studies but was generally good to very good. However, in <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a> and <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>, overall frequency of signs and symptoms was presented rather than presentation and resolution of signs and symptoms in each treatment arm. Treatment adherence relied on self reporting in all except three studies where treatment adherence was explicitly assessed by pill count (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>; <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>). None reported any difference in the number of pills remaining between the two groups. However, in the <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a> study, 40 participants were excluded because they received "less than the minimum therapy" (seven days) and these patients were distributed unevenly across the two groups (10 in the clarithromycin group and 30 in the erythromycin group). In the two studies using azithromycin microspheres (<a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>; <a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a>), the treatment adherence in the azithromycin group was 100% in both studies, because the drug was administered in a single dose under directly observed therapy (DOT) at the initial treatment visit. </p> <p>Regarding co‐interventions with other medications, most studies excluded patients whose co‐medication included certain drugs such as other antibiotics, chemotherapeutics or anti‐retrovirals. Only one study reported how many patients were excluded because of forbidden co‐medication (<a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>). </p> <p>The risk of bias in included studies was systematically assessed using 'Risk of bias' tables (<a href="./references#CD002109-bbs2-0145" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). See <a href="./references#CD002109-sec-0109" title="">Characteristics of included studies</a> table, <a href="#CD002109-fig-0003">Figure 3</a> and <a href="#CD002109-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD002109-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD002109-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD002109-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study." data-id="CD002109-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD002109-sec-0066"> <h4 class="title">Allocation</h4> <p>Only three of the included studies clearly stated the randomisation method used (using interactive voice response systems) and allocation using coded blister cards (<a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a>; <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>). More female participants and more participants with chronic obstructive pulmonary disease (COPD) or asthma (or both) received solithromycin as compared to levofloxacin in <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>. </p> </section> <section id="CD002109-sec-0067"> <h4 class="title">Blinding</h4> <p>All trials were randomised, double‐blind evaluations comparing two or more antibiotics. None of the trials reported any test of effectiveness of the blinding procedures used. </p> </section> <section id="CD002109-sec-0068"> <h4 class="title">Incomplete outcome data</h4> <p>Withdrawals were generally reported in sufficient detail. However, three studies did not report a CONSORT diagram (<a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>; <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>; <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a>). The number of patients lost to follow‐up was reported in all studies. Losses to follow‐up appeared to be minor, amounting to a maximum of 10% of the initially randomised participants. One study did not present intention‐to‐treat (ITT) analysis results (<a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>). </p> <p>Since only two studies addressed the efficacy of the same antibiotic pair and both studies provided the same information about outcomes (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>), there were no missing data issues in the combined analysis of the data arising from these two studies (<a href="#CD002109-fig-0001">Figure 1</a>; <a href="#CD002109-fig-0002">Figure 2</a>). </p> </section> <section id="CD002109-sec-0069"> <h4 class="title">Selective reporting</h4> <p>There were no obvious concerns about the selective availability of data, or selective reporting of outcomes. </p> </section> <section id="CD002109-sec-0070"> <h4 class="title">Other potential sources of bias</h4> <p>The main concern about other potential sources of bias was that nine included studies were sponsored by bio‐pharmaceutical companies manufacturing the antibiotics used in the study, or authors were closely linked with the company (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>; <a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>; <a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a>; <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a>; <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>; <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>, <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>). Funding sources were not described in two trials (<a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>; <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a>). </p> </section> </section> <section id="CD002109-sec-0071"> <h3 class="title" id="CD002109-sec-0071">Effects of interventions</h3> <section id="CD002109-sec-0072"> <h4 class="title">Primary outcome</h4> <section id="CD002109-sec-0073"> <h5 class="title">1. Test‐of‐clinical‐cure</h5> <p>The success rates for each of the treatment arms of the 11 trials are shown in the <a href="./references#CD002109-sec-0093" title="">Data and analyses</a> section of this review. 'Success' was defined as cure or improvement, be it clinical or bacteriological, as assessed at a predefined follow‐up visit ('test‐of‐cure' (TOC) visit). Overall, success rates were very high, usually ranging from 76% to 89% though they were similar in treatment and comparator arms in individual studies. Efficacy in the studies by <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> and <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a> is difficult to determine because the data are not presented clearly for treatment groups, rather the frequency of signs and symptoms is presented. Neither clinical nor statistical significance was achieved when the results of the two studies of clarithromycin versus erythromycin were pooled together (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>) (<a href="./references#CD002109-fig-0020" title="">Analysis 7.1</a>; <a href="./references#CD002109-fig-0021" title="">Analysis 7.2</a>; <a href="./references#CD002109-fig-0022" title="">Analysis 7.3</a>; <a href="./references#CD002109-fig-0023" title="">Analysis 7.4</a>). </p> </section> </section> <section id="CD002109-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD002109-sec-0075"> <h5 class="title">1. Radiological response</h5> <p>Radiological response was reported only in two studies (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>), where it was not significant despite pooling the data (<a href="./references#CD002109-fig-0020" title="">Analysis 7.1</a>; <a href="./references#CD002109-fig-0021" title="">Analysis 7.2</a>; <a href="./references#CD002109-fig-0022" title="">Analysis 7.3</a>; <a href="./references#CD002109-fig-0023" title="">Analysis 7.4</a>). </p> </section> <section id="CD002109-sec-0076"> <h5 class="title">2. Bacteriologic response</h5> <p>In the study by <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>, bacterial success rate was higher in the solithromycin group when compared to the levofloxacin group. In the <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a> study, bacteriological success favoured levofloxacin over telithromycin, while overall efficacy was not different in both these studies. In the studies by <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>, <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a> and <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>, bacteriological cure ranged from 48% to 89%. </p> <p>Detailed bacteriological data are not presented in <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> and <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a>, and only Gram stain identification was performed on sputum samples in <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> at the baseline. </p> </section> <section id="CD002109-sec-0077"> <h5 class="title">3. Adverse events</h5> <p>Detailed descriptions of adverse events were presented in all included studies. In all studies, the most common side effects attributable to the study drugs were gastrointestinal side effects. Most side effects were minor and comparable in all treatment arms, except for seven studies (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>; <a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>; <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>, <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>; <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>). In the two studies comparing clarithromycin with erythromycin (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>), there were significantly more side effects in the erythromycin group, the majority being gastrointestinal side effects. However, this was not reflected in the rate of side effects leading to withdrawal from the study, which was not significantly different across treatment arms. However, as noted above, in the <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a> study, 40 patients were excluded because they received "less than the minimum therapy" (seven days) and these patients were distributed unevenly across the two groups (10 in the clarithromycin group and 30 in the erythromycin group). Although not listed as drop‐outs due to side effects, it is quite plausible that these differences in pre‐study drop‐out rates were due to the unfavourable gastrointestinal side effects of erythromycin. In <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>, nemonoxacin demonstrated higher gastrointestinal (nausea, diarrhoea) and nervous system (dizziness, headache) adverse events compared to levofloxacin. In <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>, cethromycin demonstrated more side effects, especially dysgeusia, than clarithromycin. In <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>, gastritis and diarrhoea were higher in the high‐dose amoxicillin group (1 g three times a day) compared to the other three antibiotic groups (clarithromycin, azithromycin and levofloxacin). </p> </section> <section id="CD002109-sec-0078"> <h5 class="title">4. Hospitalisation</h5> <p>Hospitalisation was not explicitly reported as an outcome in any study.</p> </section> <section id="CD002109-sec-0079"> <h5 class="title">5. Mortality</h5> <p>Mortality was not explicitly reported as an outcome in any trial.</p> </section> <section id="CD002109-sec-0080"> <h5 class="title">Comparisons across antibiotic groups</h5> <p>Different antibiotic pairs were studied in nine studies (<a href="#CD002109-fig-0001">Figure 1</a>; <a href="#CD002109-fig-0002">Figure 2</a>). Notably, though, <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> and <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a> studied clarithromycin and amoxicillin (high‐dose amoxicillin was studied in <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> in addition to azithromycin and levofloxacin). There were no significant differences in clinical or bacteriological success, except in <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a> and <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a>. Radiological outcomes were not reported separately for the treatment arms. </p> </section> <section id="CD002109-sec-0081"> <h5 class="title">Bacteriological pathogens</h5> <p>Various pathogens were identified with varying frequency across studies. The proportion of samples yielding an identifiable pathogen ranged from 19% (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>) to 65% in <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a> (only Gram stain on sputum samples at the baseline). <i>H. influenzae</i> was the most common pathogen identified by <a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a> (62% of positive cultures) and <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a> (43% of positive cultures), whereas <i>S. pneumoniae</i> was the main causative organism in <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a> (56% of positive cultures) and <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a> (52% of positive cultures). <a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a> and <a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a> reported <i>C. pneumoniae</i> as being the most common pathogen (20% and 23% of positive cultures, respectively). In <a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a>, the bacteriological success rate (i.e. eradication of previously identified pathogen) significantly favoured levofloxacin (<a href="./references#CD002109-fig-0033" title="">Analysis 11.1</a>; <a href="./references#CD002109-fig-0034" title="">Analysis 11.2</a>; <a href="./references#CD002109-fig-0035" title="">Analysis 11.3</a>; <a href="./references#CD002109-fig-0036" title="">Analysis 11.4</a>). Most failures were due to failure to eradicate <i>H. influenzae</i> , so the authors looked at the clinical success rate of patients with <i>H. influenzae</i> at baseline, which turned out to not be significantly different between levofloxacin and telithromycin. </p> </section> <section id="CD002109-sec-0082"> <h5 class="title">Serologically identified pathogens</h5> <p>The most frequently identified pathogen was <i>M. pneumoniae</i>, which represented 22% (<a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>), 39% (<a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>), 52% (<a href="./references#CD002109-bbs2-0006" title="KohnoS , WatanabeA , AokiN , NikiY . Clinical evaluation of telithromycin for community‐acquired pneumonia ‐ phase III double‐blind comparative study of telithromycin versus levofloxacin [Japanese]. Japanese Journal of Chemotherapy2003;51(Suppl 1):255‐78. ">Kohno 2003</a>), 67% (<a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>), 69% (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>) and 74% (<a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>) of positive serology results. In addition, <i>C. pneumoniae</i> was identified in 17% of cases in the <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a> study and 7% of cases in the <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a> study. <i>Legionella pneumoniae</i> (<i>L. pneumoniae</i>) was identified in 4% and 6% in the microbiological evaluable population in the <a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a> studies respectively. In the study by <a href="./references#CD002109-bbs2-0003" title="D'IgnazioJ , CamereMA , LewisDE , JorgensenD , BreenJD . Novel, single‐dose microsphere formulation of azithromycin versus 7‐day levofloxacin therapy for treatment of mild to moderate community‐acquired pneumonia in adults. Antimicrobial Agents and Chemotherapy2005;49(10):4035‐41. ">D'Ignazio 2005</a>, <i>C. pneumoniae</i> was predominant, representing 61% of atypical pathogens. Likewise in the studies by <a href="./references#CD002109-bbs2-0004" title="DrehoblMA , DeSalvoMC , LewisDE , BreenJD . Single‐dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild‐to‐moderate community‐acquired pneumonia in adults. Chest 128;4:2230‐7. ">Drehobl 2005</a> and <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a>, <i>C. pneumoniae</i> represented just over half of atypical pathogens (53% and 52%, respectively). Only one patient tested positive for <i>L. pneumoniae</i> in the <a href="./references#CD002109-bbs2-0007" title="Mathers DunbarL , HassmanJ , TellierG . Efficacy and tolerability of once‐daily oral telithromycin compared with clarithromycin for the treatment of community‐acquired pneumonia in adults. Clinical Therapeutics2004;26(1):48‐62. ">Mathers Dunbar 2004</a> study and no samples were positive for <i>Chlamydia psittaci</i> (<i>C. psittaci</i>) in any of the studies. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002109-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002109-sec-0083"></div> <section id="CD002109-sec-0084"> <h3 class="title" id="CD002109-sec-0084">Summary of main results</h3> <p>The overwhelming feature of this review update remains the paucity of relevant evidence that could be identified and included in the review. Nonetheless, in this update, five new studies were included (<a href="./references#CD002109-bbs2-0005" title="EnglishML , FredericksCE , MilanesioNA , RohowskyN , XuZ‐Q , JentaTRJ , et al. Cethromycin versus clarithromycin for community‐acquired pneumonia: comparative efficacy and safety outcomes from two double‐blinded, randomized, parallel‐group, multicenter, multinational noninferiority studies. Antimicrobial Agents and Chemotherapy2011;56(4):2037‐47. WelteT , TorresA , NathwaniD . Clinical and economic burden of community‐acquired pneumonia among adults in Europe. Thorax2012;67:71‐9. [Welte 2012] ">English 2012</a>; <a href="./references#CD002109-bbs2-0008" title="OldachD , ClarkK , SchranzJ , DasA , CraftJC , ScottD , et al. Randomized, double‐blind, multicentre phase 2 study comparing the efficacy and safety of oral solithromycin (CEM‐101) to those of oral levofloxacin in the treatment of patients with community‐acquired bacterial pneumonia. Antimicrobial Agents and Chemotherapy2013;57(6):2526‐34. ">Oldach 2013</a>; <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>; <a href="./references#CD002109-bbs2-0010" title="VacarezzaM , PedrouzoRV , BartesaghiL , SiccaM , LerenaV , PerdomoJ , et al. Community‐acquired acute pneumonias in the adult. Controlled therapeutic study. Uruguay [Neumona aguda del adulto adquirida en la comunidad. Ensayo terapéutico controlado. Uruguay]. Archivos de Medicina Interna2010;XXXII(2‐3):31‐5. ">Vacarezza 2010</a>; <a href="./references#CD002109-bbs2-0011" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010a</a>; <a href="./references#CD002109-bbs2-0012" title="vanRensburgD , PerngR‐P , MithaIH , BesterAJ , KasumbaJ , WuR‐G , et al. Efficacy and safety of nemonoxacin versus levofloxacin for community acquired pneumonia. Antimicrobial Agents and Chemotherapy2010;54(10):4098‐106. ">van Rensburg 2010b</a>). Inclusion of these studies did not alter the conclusions of our previous reviews conducted in 2004 and 2009 (<a href="./references#CD002109-bbs2-0155" title="BjerreLM , VerheijTJ , KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD002109.pub2] ">Bjerre 2004</a>; <a href="./references#CD002109-bbs2-0156" title="BjerreLM ,  VerheijTJ ,  KochenMM . Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002109.pub3] ">Bjerre 2009</a>). </p> <p>Unfortunately, only two of the 11 studies focused on the same antibiotic pairs (<a href="./references#CD002109-bbs2-0001" title="AndersonG , EsmondeTS , ColesS , MacklinJ , CarnegieC . A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community‐acquired pneumonia. Journal of Antimicrobial Chemotherapy1997;27(Suppl A):117‐24. ">Anderson 1991</a>; <a href="./references#CD002109-bbs2-0002" title="ChienSM , PichottaP , SiepmanN , Chan CK and the Canada‐Sweden Clarithromycin‐Pneumonia Group. Treatment of community‐acquired pneumonia: a multicenter, double‐blind, randomized study comparing clarithromycin with erythromycin. Chest1993;103:697‐701. ">Chien 1993</a>), so that, once again, no formal meta‐analysis of the data could be carried out. At most, it can be stated that individual study results did not reveal significant differences in efficacy between various antibiotics and antibiotic groups, but that there were some significant differences with respect to the frequency of side effects. Given this current state of affairs, it is not possible to make strong evidence‐based recommendations regarding the choice of antibiotic to be used for the treatment of community‐acquired pneumonia in ambulatory outpatients. Under such circumstances, other factors such as tolerability, duration and frequency of treatment and cost will take on more importance in determining the choice of treatment. </p> <p>Importantly, the majority of the studies were conducted in high‐income countries and, hence, the available evidence does not adequately address the issue of community‐acquired pneumonia (CAP) or lower respiratory tract infection (LRTI) in low‐ and middle‐income countries. Lastly, antibiotic misuse is a global threat, although the antibiotic stewardship programmes are gaining some momentum in a few academic centres (<a href="./references#CD002109-bbs2-0083" title="NussenblattV , AvdicE , CosgroveS . What is the role of antimicrobial stewardship in improving outcomes of patients with CAP. Infectious Disease Clinics of North America2013;27(1):211‐28. ">Nussenblatt 2013</a>). </p> </section> <section id="CD002109-sec-0085"> <h3 class="title" id="CD002109-sec-0085">Overall completeness and applicability of evidence</h3> <p>One important reason for this lack of evidence is that a large number of the trials originally identified were conducted in hospitalised patients and therefore are not necessarily relevant to the treatment of ambulatory patients. It could be argued that the inclusion/exclusion criteria for this review were too strict and that this is the reason why so few studies were retained. However, we do believe that the criteria we applied are necessary in order to address validly the question of the efficacy of treatment of CAP in ambulatory patients. In particular, it could be argued that the decision to exclude studies based on size is not desirable, since one aim of the review is to pool results and that each study therefore would contribute some information. However, we felt that this criterion was necessary to exclude studies where the number of patients with pneumonia was so small that randomisation could no longer be expected to achieve a balanced distribution of confounders, both known and unknown, across study groups. </p> <p>As for the requirement that the diagnosis of CAP be confirmed by a chest radiograph, we felt that this was necessary to avoid diagnostic misclassification, which could, for example, have led to the inclusion of patients with bronchitis in this review. This could have biased the estimation of the efficacy of various antibiotic treatments, either differentially or non‐differentially, depending on the distribution of non‐CAP cases across treatment groups. Indeed, most recent clinical guidelines recommend the routine use of chest X‐rays to confirm a suspected pneumonia (<a href="./references#CD002109-bbs2-0127" title="LimWS , BaudouiSV , GeorgeRC , HillAT , JamiesonC , LeJeuneI , et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax2009;64(Suppl 3):iii1‐iii55. ">BTS 2009</a>; <a href="./references#CD002109-bbs2-0136" title="MandellLA , WunderinkRG , AnzuetoA , BartlettJG , CampbellGD , DeanNC , et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community‐acquired pneumonia in adults. Clinical Infectious Diseases2007;44(Suppl 2):27‐72. ">IDSA/ATS 2007</a>; <a href="./references#CD002109-bbs2-0154" title="WoodheadM ,  BlasiF ,  EwigS ,  GarauJ ,  HuchonG ,  IevenM ,  etal . Guidelines for the management of adult lower respiratory tract infections‐‐full version. Clinical Microbiology and Infection2011;17(Suppl 6):E1‐59. ">Woodhead 2011</a>; <a href="./references#CD002109-bbs2-0117" title="WunderinkRG , LaterrePF , FrancoisB , PerrotinD , ArtigasA , VidalLO , et al. Recombinant tissue factor pathway inhibitor in severe community‐acquired pneumonia: a randomized trial. American Journal of Respiratory and Critical Care Medicine2011;183(11):1561‐8. ">Wunderink 2011</a>). However, we are aware that this diagnostic test is often not used in practice and that patients are therefore treated empirically according to the clinical findings and the severity of the clinical picture. In such a situation, patients with an empirical diagnosis of pneumonia (i.e. diagnosis without chest X‐ray) are probably, on average, less severely ill than the participants in the trials we reviewed. </p> <p>The diversity of pathogens identified as the most common causative organisms in our present review underscores the need for conducting studies of CAP treatment in a variety of different geographical locations. This also points to a possible limitation of such studies, namely their questionable generalisability to different clinical and geographical situations than the ones included in the present studies. For example, studies conducted in low‐ and middle‐income countries might have a different bacteriological profile than those conducted in high‐income countries. </p> <p>Finally, a lot of potentially useful information is lost because investigators often included a mix of in‐ and outpatients in their studies without reporting results separately for each of these subgroups. Investigators and journal editors should be strongly encouraged to report such data separately, as these patients have different co‐morbidity profiles and, potentially, respond to treatment differently. Putting heterogeneous patient groups into the same analytic basket may reduce the generalisability and thus the usefulness of such study results. Contacting trial authors after publication to get additional data, sometimes years after a study was published, is a time‐consuming process with a very low yield, as was our experience and that of other Cochrane review authors (<a href="./references#CD002109-bbs2-0146" title="RobenshtokE , ShefetD , Gafter‐GviliA , PaulM , VidalL , LeiboviciL . Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD004418.pub3] ">Robenshtok 2008</a>). </p> </section> <section id="CD002109-sec-0086"> <h3 class="title" id="CD002109-sec-0086">Quality of the evidence</h3> <p>Overall, the quality of the included studies was relatively good, although there were some differences in the completeness of reporting. The fact that we chose to include only double‐blind, controlled, prospective randomised controlled trials (RCTs) led to a priori exclusion of studies of lesser quality. </p> </section> <section id="CD002109-sec-0087"> <h3 class="title" id="CD002109-sec-0087">Potential biases in the review process</h3> <p>By choosing to include only studies published in peer‐reviewed journals and by choosing no longer to contact pharmaceutical companies for information on unpublished studies, we believe that we have contributed to increasing study quality and reducing bias in our review to a minimum. Furthermore, by excluding data from studies focusing on selected subgroups of ambulatory participants (such as participants with suspected bacterial pneumonia), we believe we have maximised the generalisability of our review results to unselected patients presenting to their physician. </p> <p>It is noteworthy that, once again, nine studies meeting the inclusion criteria for our review were sponsored by bio‐pharmaceutical companies. This could potentially introduce a publication bias, as it would be in the interest of manufacturers not to publish studies yielding unfavourable results about their products. We are of the opinion that there is an urgent need for industry‐independent research into the treatment of CAP in ambulatory patients. </p> </section> <section id="CD002109-sec-0088"> <h3 class="title" id="CD002109-sec-0088">Agreements and disagreements with other studies or reviews</h3> <p>As mentioned above, we feel that our decision to exclude studies focusing only on a subset of outpatients (for example, "only bacteriologically evaluable patients" or "excluding patients with atypical pneumonia") is necessary to maintain the generalisability of our results to patients presenting to first‐line physicians. In contrast, a recent meta‐analysis we encountered in the process of searching the literature was more inclusive (<a href="./references#CD002109-bbs2-0142" title="MaimonN , NopmaneejumruslersC , MarrasTK . Antibacterial class is not obviously important in outpatient pneumonia: a meta‐analysis. European Respiratory Journal2008;31(5):1068‐76. ">Maimon 2008</a>). The object of this meta‐analysis was different from that of our review. However, the target population (outpatients with CAP, treated as outpatients) was the same. Despite the authors' stated focus on "the inclusion of only randomised prospective double‐blind studies using only oral therapy exclusively in outpatients" (p.1974), this work included a number of open‐label (non‐blinded) studies, studies including a mix of in‐ and outpatients (for which subgroup data were reportedly obtained from study authors) as well as narrow‐focus studies (i.e. studies focusing exclusively on bacterial pneumonia, for example). Of the 13 studies included in this meta‐analysis, none met the inclusion criteria for our review, which leads us to question the generalisability of the results of this meta‐analysis to unselected patients presenting in general practice. </p> <p>Finally, a recent RCT confirmed that patients with CAP of moderate severity (Fine Score II or III) can be treated as outpatients, just as safely and effectively as inpatients (<a href="./references#CD002109-bbs2-0128" title="CarratalàJ , Fernández‐SabéN , OrtegaL , CastellsaguéX , RosónB , DorcaJ , et al. Outpatient care compared with hospitalization for community‐acquired pneumonia: a randomized trial in low‐risk patients. Annals of Internal Medicine2005;142(3):165‐72. ">Carratalà 2005</a>), at only a fraction of the cost. This further underscores the need for solid, evidence‐based data on the treatment of patients with CAP in the ambulatory care setting. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD002109-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Figure1: Antibiotic comparisons in new studies included in this review. The red arrow indicates antibiotic comparisons studied in Udupa 2011." data-id="CD002109-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Figure1: Antibiotic comparisons in new studies included in this review. The red arrow indicates antibiotic comparisons studied in <a href="./references#CD002109-bbs2-0009" title="UdupaA , GuptaP . Antibiotic therapy in pneumonia: a comparative study of oral antibiotics in a rural healthcare centre. International Journal of Pharmacy and Pharmaceutical Sciences2011;3:156‐8. ">Udupa 2011</a>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Figure 2. Overview of included studies and antibiotic pairs studied in 2009 review. *Indicates studies new to this review; shaded ovals indicate quinolones (gyrase inhibitors), white ovals indicate macrolides" data-id="CD002109-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Figure 2. Overview of included studies and antibiotic pairs studied in 2009 review. *Indicates studies new to this review; shaded ovals indicate quinolones (gyrase inhibitors), white ovals indicate macrolides </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD002109-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study." data-id="CD002109-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/full#CD002109-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Solithromycin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0005" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Solithromycin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Solithromycin versus levofloxacin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0006" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Solithromycin versus levofloxacin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Solithromycin versus levofloxacin, Outcome 3 Adverse events." data-id="CD002109-fig-0007" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Solithromycin versus levofloxacin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Nemonoxacin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0008" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Nemonoxacin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Nemonoxacin versus levofloxacin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0009" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Nemonoxacin versus levofloxacin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Nemonoxacin versus levofloxacin, Outcome 3 Adverse events." data-id="CD002109-fig-0010" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Nemonoxacin versus levofloxacin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Nemonoxacin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0011" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Nemonoxacin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Nemonoxacin versus levofloxacin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0012" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Nemonoxacin versus levofloxacin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Nemonoxacin versus levofloxacin, Outcome 3 Adverse events." data-id="CD002109-fig-0013" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Nemonoxacin versus levofloxacin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Clarithromycin versus amoxicillin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0014" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Clarithromycin versus amoxicillin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0015"> <p> <div class="table" id="CD002109-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Antibiotics</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clarithromycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Azithromycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Levofloxacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High‐dose amoxicillin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Clarithromycin versus azithromycin versus levofloxacin versus amoxicillin, Outcome 1 Test‐of‐clinical‐cure. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0015">Navigate to figure in review</a></div> </div> <div class="figure" id="CD002109-fig-0016"> <p> <div class="table" id="CD002109-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Antibiotic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clarithromycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Azithromycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Levofloxacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Udupa 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amoxicillin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Clarithromycin versus azithromycin versus levofloxacin versus amoxicillin, Outcome 2 Adverse events. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0016">Navigate to figure in review</a></div> </div> <div class="figure" id="CD002109-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cethromycin versus clarithromycin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0017" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Cethromycin versus clarithromycin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cethromycin versus clarithromycin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0018" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Cethromycin versus clarithromycin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cethromycin versus clarithromycin, Outcome 3 Adverse events." data-id="CD002109-fig-0019" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Cethromycin versus clarithromycin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Clarithromycin versus erythromycin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0020" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Clarithromycin versus erythromycin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Clarithromycin versus erythromycin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0021" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Clarithromycin versus erythromycin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Clarithromycin versus erythromycin, Outcome 3 Radiological cure." data-id="CD002109-fig-0022" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Clarithromycin versus erythromycin, Outcome 3 Radiological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Clarithromycin versus erythromycin, Outcome 4 Adverse events." data-id="CD002109-fig-0023" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Clarithromycin versus erythromycin, Outcome 4 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Azithromycin microspheres versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0024" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Azithromycin microspheres versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Azithromycin microspheres versus levofloxacin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0025" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Azithromycin microspheres versus levofloxacin, Outcome 2 Bacteriological cure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Azithromycin microspheres versus levofloxacin, Outcome 3 Adverse events." data-id="CD002109-fig-0026" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Azithromycin microspheres versus levofloxacin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Azithromycin microspheres versus clarithromycin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0027" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Azithromycin microspheres versus clarithromycin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Azithromycin microspheres versus clarithromycin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0028" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Azithromycin microspheres versus clarithromycin, Outcome 2 Bacteriological cure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Azithromycin microspheres versus clarithromycin, Outcome 3 Adverse events." data-id="CD002109-fig-0029" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Azithromycin microspheres versus clarithromycin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Telithromycin versus clarithromycin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0030" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Telithromycin versus clarithromycin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Telithromycin versus clarithromycin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0031" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Telithromycin versus clarithromycin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Telithromycin versus clarithromycin, Outcome 3 Adverse events." data-id="CD002109-fig-0032" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Telithromycin versus clarithromycin, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Telithromycin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure." data-id="CD002109-fig-0033" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Telithromycin versus levofloxacin, Outcome 1 Test‐of‐clinical‐cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Telithromycin versus levofloxacin, Outcome 2 Bacteriological cure." data-id="CD002109-fig-0034" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Telithromycin versus levofloxacin, Outcome 2 Bacteriological cure.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Telithromycin versus levofloxacin, Outcome 3 Clinical efficacy against H. influenzae." data-id="CD002109-fig-0035" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Telithromycin versus levofloxacin, Outcome 3 Clinical efficacy against <i>H. influenzae</i>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002109-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/urn:x-wiley:14651858:media:CD002109:CD002109-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_t/tCD002109-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Telithromycin versus levofloxacin, Outcome 4 Adverse events." data-id="CD002109-fig-0036" src="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Telithromycin versus levofloxacin, Outcome 4 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/media/CDSR/CD002109/image_n/nCD002109-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Solithromycin versus levofloxacin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.32, 2.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.28, 6.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.19, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Solithromycin versus levofloxacin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Nemonoxacin versus levofloxacin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.55, 2.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.19, 3.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.73, 2.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Nemonoxacin versus levofloxacin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Nemonoxacin versus levofloxacin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.38, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.13, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.47, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Nemonoxacin versus levofloxacin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Clarithromycin versus amoxicillin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Clarithromycin versus amoxicillin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Clarithromycin versus azithromycin versus levofloxacin versus amoxicillin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Clarithromycin versus azithromycin versus levofloxacin versus amoxicillin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Cethromycin versus clarithromycin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1025</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.63, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.50, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1096</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [1.32, 2.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Cethromycin versus clarithromycin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Clarithromycin versus erythromycin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.27 [0.66, 7.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.03, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Radiological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.33, 2.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.20, 0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Clarithromycin versus erythromycin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Azithromycin microspheres versus levofloxacin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.27, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.32, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [1.04, 3.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Azithromycin microspheres versus levofloxacin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Azithromycin microspheres versus clarithromycin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.31, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.52, 2.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.73, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Azithromycin microspheres versus clarithromycin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Telithromycin versus clarithromycin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.49, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.08, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Telithromycin versus clarithromycin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002109-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Telithromycin versus levofloxacin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Test‐of‐clinical‐cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.14, 5.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bacteriological cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical efficacy against <i>H. influenzae</i> <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.62 [0.38, 55.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.58, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Telithromycin versus levofloxacin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002109.pub4/references#CD002109-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002109.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD002109-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002109-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD002109-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD002109-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD002109-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD002109-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD002109-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002109\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002109\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002109\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002109\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002109\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002109.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002109.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002109.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002109.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002109.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718269893"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002109.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718269897"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002109.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcc395ec3f3fd',t:'MTc0MDcxODI3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 